Free Access
Med Sci (Paris)
Volume 21, Number 6-7, Juin–Juillet 2005
Page(s) 613 - 617
Section M/S revues
Published online 15 June 2005
  1. Pavlou AK, Reichert JM. Recombinant protein therapeutics: success rates, market trends and values to 2010. Nat Biotechnol 2004; 22 : 1513–9. [Google Scholar]
  2. Braun P, LaBaer J. High throughput protein production for functional proteomics. Trends Biotechnol 2003; 21 : 383–8. [Google Scholar]
  3. Gustafsson C, Govindarajan S, Minshull J. Codon bias and heterologous protein expression. Trends Biotechnol 2004; 22 : 346–53. [Google Scholar]
  4. Brekke OH, Sandlie I. Therapeutic antibodies for human diseases at the dawn of the twenty-first century. Nat Rev Drug Discov 2003; 2 : 52–62. [Google Scholar]
  5. Gerngross TU. Advances in the production of human therapeutic proteins in yeast and filamentous fungi. Nat Biotechnol 2004; 22 : 1409–14. [Google Scholar]
  6. Wurm FM. Production of recombinant protein therapeutics in cultivated mammalian cells. Nat Biotechnol 2004; 22 : 1393–8. [Google Scholar]
  7. Hellwig S, Drossard J, Twyman RM, Fischer R. Plant cell cultures for the production of recombinant proteins. Nat Biotechnol 2004; 22 : 1415–22. [Google Scholar]
  8. Ritz D, Beckwith J. Roles of thiol-redox pathways in bacteria. Annu Rev Microbiol 2001; 55 : 21–48. [Google Scholar]
  9. Wilkinson B, Gilbert HF. Protein disulfide isomerase. Biochem Biophys Acta 2004; 1699 : 35–44. [Google Scholar]
  10. Spirin AS. High-throughput cell-free systems for synthesis of functionally active proteins. Trends Biotechnol 2004; 22. [Google Scholar]
  11. Betton JM. Rapid translation system (RTS): a promising alternative for recombinant protein production. Curr Protein Pept Sci 2003; 4 : 73–80. [Google Scholar]
  12. Braun P, Hu Y, Shen B, et al. Proteome-scale purification of human proteins from bacteria. Proc Natl Acad Sci USA 2002; 99 : 2654–9. [Google Scholar]
  13. Kiefhaber T, Rudolph R, Kohler H-H, Buchner J. Protein aggregation in vitro and in vivo: a quantitative model of the kinetic competition between folding and aggregation. Biotechnology 1991; 9 : 825–9. [Google Scholar]
  14. Fink AL. Protein aggregation: folding aggregates, inclusion bodies and amyloid. Fold Design 1998; 3 : R9–23. [Google Scholar]
  15. Carrio MM, Villaverde A. Construction and deconstruction of bacterial inclusion bodies. J Biotechnol 2002; 96 : 3–12. [Google Scholar]
  16. Fischer G, Tradler T, Zarnt T. The mode of action of peptidyl prolyl cis/trans isomerases in vivo: binding versus catalysis. FEBS Lett 1998; 426 : 17–20. [Google Scholar]
  17. Wickner S, Maurizi MR, Gottesman S. Posttranslational quality control: folding, refolding, and degrading proteins. Science 1999; 286 : 1888–93. [Google Scholar]
  18. Middelberg APJ. Preparative protein refolding. Trends Biotechnol 2002; 20 : 437–43. [Google Scholar]
  19. Baneyx F, Mujacic M. Recombinant protein folding and misfolding in Escherichia coli. Nat Biotechnol 2004; 22 : 1399–408. [Google Scholar]
  20. Clark ED, Schwartz E, Rudolph R. Inhibition of aggregation side reactions during in vitro protein folding. Meth Enzymol 1999; 309 : 217–36. [Google Scholar]
  21. Waldo GS, Standish BM, Berendzen J, Terwilliger TC. Rapid protein-folding assay using green fluorescent protein. Nat Biotechnol 1999; 17 : 691–5. [Google Scholar]
  22. Cabantous S, Terwilliger TC, Waldo GS. Protein tagging and detection with engineered self-assembling fragments of green fluorescent protein. Nat Biotechnol 2005; 23 : 102–7. [Google Scholar]
  23. Chirino AJ, Mire-Sluis A. Characterizing biological products and assessing comparability following manufacturing changes. Nat Biotechnol 2004; 22 : 1383–91. [Google Scholar]
  24. Zhang Z, Gildersleeve J, Yang YY, et al. A new strategy for the synthesis of glycoproteins. Science 2004; 303 : 371–3. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.